SCNX Scienture Holdings, Inc.
$3.23▲ +10.24%
Healthcare
Other
Volume 37.1K
Avg Volume (10D) 82.1K
Key Metrics & Fundamentals
Market Cap
$5.31M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.64 - 30.45
% vs 50 MA
-52.69%
% vs 200 MA
-65.40%
RSI-14
29.3
MACD Histogram
+0.1400
Beta (1Y vs SPY)
1.57
Free Cash Flow
-$9.18M
Gross Rev
$343,639
Gross Profit
$335,779
EBITDA
-$2.09M
COGS
$7,860
Operating Exp
$3.04M
Operating Income
-$2.70M
EBIT
-$2.70M
Pretax Income
-$2.82M
Net Income
-$2.82M
EPS (Diluted)
-0.07
Price & Volume History
Loading chart…
Recent News
SCIENTURE Issues Shareholder Letter Highlighting Sequential Revenue Growth, Two FDA-Approved Commercial Products, and Continued Progress Toward Profitability in 2027
GlobeNewswire · Oct 22, 2026 8:05 AM ET
SCIENTURE Reports Approximately $1.22 Million in Unaudited Preliminary Q3 2026 Revenue, Achieving 256% Sequential Growth
GlobeNewswire · Oct 13, 2026 8:05 AM ET
EXCLUSIVE: Scienture Revenue Soars 256% As Drugmaker Targets 2027 Profitability
Benzinga · Oct 13, 2026 7:45 AM ET
BC-Most Active Stocks
Associated Press · Oct 2, 2026 10:30 AM ET
SCIENTURE Announces Arbli™ Added to Formularies at Three Leading U.S. Pediatric Academic Medical Centers and Hospitals
GlobeNewswire · Oct 2, 2026 8:05 AM ET
EXCLUSIVE: Scienture Expands Institutional Reach for Hypertension Drug with New Hospital Adoptions
Benzinga · Oct 2, 2026 7:46 AM ET
Scienture Holdings, Inc. Announces Reverse Stock Split
GlobeNewswire · Sep 30, 2026 4:05 PM ET
SCIENTURE Expands Commercial Reach of REZENOPY™ to Addiction Treatment Centers through an Agreement with a Distribution Partner
GlobeNewswire · Sep 22, 2026 8:15 AM ET
SCIENTURE to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026
GlobeNewswire · Sep 9, 2026 8:55 AM ET
SCIENTURE Reports Q2 2026 Results with Approximately 510% Sequential Revenue Growth from Q1 2026 and Significant Improvement in Operating Performance
GlobeNewswire · Aug 14, 2026 8:08 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See SCNX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.